Evidence map›Paper›PMID 30874586›Full record

ArticleScientific reports2019

DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro.

M Verheijen, M Lienhard, Y Schrooders, O Clayton, R Nudischer, S Boerno, B Timmermann, N Selevsek, R Schlapbach, H Gmuender and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Intracellular Delivery of Hydrophilic Glycans Using Superchaotropic Clusters.Angewandte Chemie (International ed. in English) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Lessons From Drug Discovery for Cryoprotective Agent Design: An AI-Oriented Perspective.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

M VerheijenToxicogenomics, Maastricht University, Maastricht, Netherlands.
M LienhardComputational Molecular Biology, Max-Planck-Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0002-2549-3142
Y SchroodersToxicogenomics, Maastricht University, Maastricht, Netherlands.
O ClaytonF. Hoffmann-La Roche AG, Basel, Switzerland.
R NudischerF. Hoffmann-La Roche AG, Basel, Switzerland.
S BoernoComputational Molecular Biology, Max-Planck-Institute for Molecular Genetics, Berlin, Germany.
B TimmermannComputational Molecular Biology, Max-Planck-Institute for Molecular Genetics, Berlin, Germany.
N SelevsekFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
R SchlapbachFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich, Switzerland.
H GmuenderGenedata AG, Basel, Switzerland.
S GottaGenedata AG, Basel, Switzerland.
J GeraedtsGenetics and Cell Biology, Maastricht University, Medical Center, Maastricht, Netherlands.
R HerwigComputational Molecular Biology, Max-Planck-Institute for Molecular Genetics, Berlin, Germany.
J KleinjansToxicogenomics, Maastricht University, Maastricht, Netherlands.
F CaimentToxicogenomics, Maastricht University, Maastricht, Netherlands. florian.caiment@maastichtuniversity.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Though clinical trials for medical applications of dimethyl sulfoxide (DMSO) reported toxicity in the 1960s, later, the FDA classified DMSO in the safest solvent category. DMSO became widely used in many biomedical fields and biological effects were overlooked. Meanwhile, biomedical science has evolved towards sensitive high-throughput techniques and new research areas, including epigenomics and microRNAs. Considering its wide use, especially for cryopreservation and in vitro assays, we evaluated biological effect of DMSO using these technological innovations. We exposed 3D cardiac and hepatic microtissues to medium with or without 0.1% DMSO and analyzed the transcriptome, proteome and DNA methylation profiles. In both tissue types, transcriptome analysis detected >2000 differentially expressed genes affecting similar biological processes, thereby indicating consistent cross-organ actions of DMSO. Furthermore, microRNA analysis revealed large-scale deregulations of cardiac microRNAs and smaller, though still massive, effects in hepatic microtissues. Genome-wide methylation patterns also revealed tissue-specificity. While hepatic microtissues demonstrated non-significant changes, findings from cardiac microtissues suggested disruption of DNA methylation mechanisms leading to genome-wide changes. The extreme changes in microRNAs and alterations in the epigenetic landscape indicate that DMSO is not inert. Its use should be reconsidered, especially for cryopreservation of embryos and oocytes, since it may impact embryonic development.

Indexed as

Biological PhenomenaCryopreservationCryoprotective AgentsDimethyl SulfoxideDNA MethylationEmbryonic DevelopmentEpigenesis, GeneticEpigenomicsFemaleGene Expression ProfilingHepatocytesHumansMaleMicroRNAsMyocytes, CardiacOocytesCryoprotective AgentsDimethyl SulfoxideMicroRNAsSolvents

Identifiers

PMID30874586
PMCPMC6420634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.